Correction to: Significance of upfront cytoreductive nephrectomy stratified by IMDC risk for metastatic renal cell carcinoma in targeted therapy era - a multi‑institutional retrospective study

Affiliations

• ¹ Department of Urology, Iwate Medical University School of Medicine, 2-1-1 Idaidori, Yahaba-cho, Shiwa, 028-3695, Japan. rekato@iwate-med.ac.jp.
• ² Department of Urology, Yamagata University School of Medicine, 2-2-2 Iida-Nishi, Yamagata, 990-9585, Japan.
• ³ Department of Urology, Akita University School of Medicine, 1-1-1 Hondo, Akita, 010-8543, Japan.
• ⁴ Department of Urology and Advanced Blood Purification Therapy, Hirosaki University Graduate of Medicine, 5 Zaifuchou, Hirosaki, 036-8562, Japan.
• ⁵ Department of Urology, Fukushima Medical University School of Medicine, 1 Hikarigaoka, Fukushima, 960-1295, Japan.
• ⁶ Department of Urology, University of Tsukuba Graduate School of Medicine, 1-1-1 Tennodai, Tsukuba, 305-8575, Japan.
• ⁷ Department of Urology, Tohoku University School of Medicine, 2-1 Seiryo-machi, Aoba-ku, Sendai, 980-8575, Japan.
• ⁸ Department of Urology, Miyagi Cancer Center, 47-1, Nodayama, Shiote, Aijima, Natori, 981-1293, Japan.
• ⁹ Department of Urology, Iwate Medical University School of Medicine, 2-1-1 Idaidori, Yahaba-cho, Shiwa, 028-3695, Japan.